Decline depth
-35.8%
From rolling 252-day high of $28.00, 293d ago.
Past the 30% Amber threshold.
Amber List Recovering
STVN
Stevanato Group S.p.A.
Healthcare · Medical Instruments & Supplies · mid-cap ($3.8B)
-35.8%
from rolling 252-day high of $28.00 set 2025-07-25 · 293d ago
Current
$17.99
Decline depth
-35.8%
Decline σ
3.0σ
TFC
4/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
STVN qualifies for the Amber List on decline depth.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 4/5 Amber threshold.
Decline sigma
3.0σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (2.56% per day).
The structural read
What price action says about STVN.
STVN qualifies for the Amber List on decline depth — down -35.8% from its rolling 252-day high.
Cross-confirmation: also showing 4/5 bearish time frames.
Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.
Upstream TFC read: moderate alignment, current phase daily. Last bar types — daily 1 (green), weekly 1 (red), monthly 2U (green).
Earnings on file: 2026-03-04. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $12.89
33.8% of range
52W high $28.00
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
93
Red List
42
Amber
47
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to STVN
Amber List
DXCM
DexCom, Inc.
Amber List
CRSP
CRISPR Therapeutics AG
Red List
VNDA
Vanda Pharmaceuticals Inc.
Amber List Recovering
CORT
Corcept Therapeutics Incorporat
Red List
TENX
Tenax Therapeutics, Inc.
Amber List
XNCR
Xencor, Inc.
Questions about STVN
What people ask.
Why is STVN on Broken Stocks?
STVN qualifies for the Amber List on decline depth. It is down -35.8% from its rolling 252-day high of $28.00, set on 2025-07-25 — 293d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for STVN?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — STVN is still Amber List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is STVN a falling knife?
Not by the strict technical definition. STVN is down -35.8% from its 52-week high, but that high was set 293d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. STVN is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is STVN a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is STVN trading inside its 52-week range?
At $17.99, STVN sits 33.8% of the way from its 52-week low ($12.89) to its 52-week high ($28.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has STVN been declining?
The current 35.8% decline accrued over 293d, which annualizes to roughly -44.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does STVN compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 54 showing recovering structural signals. Median sector decline is -35.8% — STVN's decline is shallower than the sector median.
Does STVN's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-03-04) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.